McNeil AB: Clinical Trials

44 trials sponsored by McNeil AB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 1 recruiting, 1 terminated, 1 withdrawn. 16 Phase 1, 15 Not applicable, 5 Phase 3, 4 Phase 4, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 116Completed 15, Withdrawn 1
Not applicable15Completed 15
Phase 35Completed 4, Terminated 1
Phase 44Completed 4
Phase 23Completed 2, Recruiting 1
Early Phase 11Completed 1

Follow McNeil AB: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker Volunteers
Nicotine Mint Oro Dispersible Tablet (Nic ODT), Placebo Oro Dispersible Tablet (Placebo ODT) - Smoking Cessation, Nicotine Replacements Therapy
Phase 2RecruitingMcNeil AB2802026-10-052026-10-23
A Study of Butamirate Citrate Syrup Versus (vs) Sinecod Syrup (Vanilla) in Adult Healthy Study Volunteers
Butamirate citrate, Sinecod - Healthy
Phase 1WithdrawnMcNeil AB2022-03-182022-05-20
A Study of Combination Caplet With Loperamide Hydrochloride and Simethicone, and Imodium Express Tablets-lyophilizate Coadministered With Espumisan Capsule in Healthy Volunteers
Combination Caplet with Loperamide HCl and Simethicone, Loperamide HCl, Simethicone - Healthy
Phase 1CompletedMcNeil AB482019-12-052020-09-10
A Study to Assess Bioquivalence Between a Novel Naproxen Sodium 275 mg Film-coated Tablet and Nalgesin Naproxen Sodium 275 mg Film-coated Tablet in Healthy Adult Volunteers
Naproxen sodium (test product), Naproxen sodium (reference product) - Healthy
Phase 1CompletedMcNeil AB282018-12-032020-01-23
A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.
xylo+dex nasal spray (0.1 mg+5 mg/dose), Nasic - Nasal Congestion
Phase 3CompletedMcNeil AB1402018-02-262018-10-18
A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.
Benzocaine 8 mg, Placebo - Sore Throat
Phase 3CompletedMcNeil AB2602018-02-022018-10-18
Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and NicoretteĀ® Mint Gum in Healthy Smokers
Nicorette Extra Mint 2 mg Gum, Nicorette Mint 2 mg Gum, Nicorette Extra Mint 4mg Gum - Tobacco Dependence
Phase 1CompletedMcNeil AB762017-08-142019-01-03
A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.
Nicorette Strongmint lozenge 4 mg, Niquitin MiniMint lozenge 4 mg - Tobacco Dependence
Phase 1CompletedMcNeil AB2442017-03-202018-07-27
Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
Nicotine Spray, Placebo - Tobacco Dependence
Phase 3CompletedMcNeil Consumer Healthcare Division of McNEIL-PPC, Inc.11982015-01-312019-01-08
Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in Stores
Ibuprofen - Pain
Phase 1CompletedMcNeil AB322012-02-012012-07-10
A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common Cold
Polymeric Nasal Spray, Sham Nasal Spray - Common Cold
Not applicableCompletedMcNeil AB1632012-01-012012-05-09
Study to Compare the Pharmacokinetics Profiles of Four Racecadotril Products
Racecadotril - Diarrhea
Phase 1CompletedMcNeil AB242011-12-012012-07-10
An Exploratory Study Comparing Two Nicotine Inhalers
Nicotine - Tobacco Dependence
Early Phase 1CompletedMcNeil AB362011-11-012012-07-10
Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine Gum
Nicotine - Tobacco Dependence
Not applicableCompletedMcNeil AB3462011-04-012012-07-10
Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking
Placebo, Nicotine - Tobacco Dependence
Phase 3TerminatedMcNeil Consumer Healthcare Division of McNEIL-PPC, Inc.2572011-03-012012-04-23
Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products
Nicotine - Tobacco Dependence
Phase 1CompletedMcNeil AB502011-02-012012-07-10
A Study to Test Bioequivalence Between One Test Formulation of Ibuprofen and Two Reference Treatments
Ibuprofen - Pain
Phase 1CompletedMcNeil AB302011-02-012012-07-10
To Test Bioequivalence Between Two Tablet Formulations in the Treatment of Allergy
Cetirizine - Allergy
Phase 1CompletedMcNeil AB362011-02-012012-07-10
Bioequivalence Between a Racecadotril Capsule and Film-Coated Tablet (FCT) to Treat Diarrhea in Adults
Racecadotril Film-Coated Tablet (FCT), Racecadotril Capsule - Antidiarrheals
Phase 1CompletedMcNeil AB402011-01-012012-07-10
Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products
Nicotine Medicated Gum, 4 mg Nicotine Gum, 2 mg Nicotine Gum - Tobacco Dependence
Not applicableCompletedMcNeil AB442010-10-012012-07-10

Showing 20 of 44. Sign in to see all of them.

Conditions studied

Smoking Cessation (24)  ·  Tobacco Use Disorder (20)  ·  Nasal Obstruction (3)  ·  Common Cold (2)  ·  Diarrhea (2)  ·  Headache (2)  ·  Pain (2)  ·  Tooth Discoloration (2)  ·  Hypersensitivity (1)  ·  Pharyngitis (1)  ·  Respiratory Tract Infections (1)

Interventions

Nicotine (14)  ·  Nicotine Chewing Gum (9)  ·  Tobacco Use Cessation Devices (8)  ·  Acetaminophen (2)  ·  Ibuprofen (2)  ·  Loperamide (2)  ·  Nicotine Replacement Therapy (2)  ·  Simethicone (2)  ·  racecadotril (2)  ·  Benzocaine (1)  ·  Cetirizine (1)  ·  Chewing Gum (1)  ·  Espumisan (1)  ·  Influenza Vaccines (1)  ·  Naproxen (1)

Countries

Sweden (16)  ·  Russia (6)  ·  Canada (5)  ·  Germany (5)  ·  China (2)  ·  Ireland (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Belgium (1)  ·  Czechia (1)  ·  Denmark (1)  ·  India (1)  ·  Mexico (1)

Top investigators

Elisabeth Kruse, PhD (31)  ·  Elisabeth A Kruse, PhD (2)  ·  Konstantin A Zakharov, MD (2)  ·  Alison Hughes (1)  ·  Andrew Myers, MD (1)  ·  Daniel Qi, MD (1)  ·  Dmitry Lioznov, MD (1)  ·  Elena P Mazygula, MD (1)  ·  Jackie Mao (1)  ·  Konstantin A. Zacharov, MD (1)  ·  Konstantin Anatolyevich Zacharov (1)  ·  Shi Aixin, M. Pharm (1)  ·  Steven Sacavage (1)  ·  Tatiana E Morozova, MD (1)  ·  Vladimir Popov, MD (1)

Results publications

PMID 22523363, PMID 22695211, PMID 26541878, PMID 30452732

NIH funding

2008 (8), 2005 (3), 2009 (2)